JP2006522659A - 皮下用心臓デバイス - Google Patents
皮下用心臓デバイス Download PDFInfo
- Publication number
- JP2006522659A JP2006522659A JP2006509832A JP2006509832A JP2006522659A JP 2006522659 A JP2006522659 A JP 2006522659A JP 2006509832 A JP2006509832 A JP 2006509832A JP 2006509832 A JP2006509832 A JP 2006509832A JP 2006522659 A JP2006522659 A JP 2006522659A
- Authority
- JP
- Japan
- Prior art keywords
- configuration
- cardiac
- electrode
- lead
- heart
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000007920 subcutaneous administration Methods 0.000 title claims abstract description 109
- 210000002216 heart Anatomy 0.000 title claims description 166
- 230000000747 cardiac effect Effects 0.000 claims abstract description 483
- 230000000638 stimulation Effects 0.000 claims abstract description 112
- 238000001514 detection method Methods 0.000 claims abstract description 103
- 238000002560 therapeutic procedure Methods 0.000 claims abstract description 87
- 210000000115 thoracic cavity Anatomy 0.000 claims abstract description 54
- 230000000694 effects Effects 0.000 claims abstract description 50
- 238000012544 monitoring process Methods 0.000 claims abstract description 23
- 230000006870 function Effects 0.000 claims description 149
- 238000000034 method Methods 0.000 claims description 131
- 238000011282 treatment Methods 0.000 claims description 68
- 206010003119 arrhythmia Diseases 0.000 claims description 56
- 230000001746 atrial effect Effects 0.000 claims description 53
- 230000006793 arrhythmia Effects 0.000 claims description 50
- 230000002861 ventricular Effects 0.000 claims description 49
- 230000004044 response Effects 0.000 claims description 32
- 230000035939 shock Effects 0.000 claims description 31
- 230000033764 rhythmic process Effects 0.000 claims description 27
- 208000001871 Tachycardia Diseases 0.000 claims description 26
- 230000006854 communication Effects 0.000 claims description 24
- 238000004891 communication Methods 0.000 claims description 24
- 230000015654 memory Effects 0.000 claims description 19
- 238000013194 cardioversion Methods 0.000 claims description 17
- 239000011159 matrix material Substances 0.000 claims description 17
- 238000012360 testing method Methods 0.000 claims description 17
- 238000011272 standard treatment Methods 0.000 claims description 16
- 206010049447 Tachyarrhythmia Diseases 0.000 claims description 14
- 206010047302 ventricular tachycardia Diseases 0.000 claims description 14
- 238000003745 diagnosis Methods 0.000 claims description 13
- 238000010168 coupling process Methods 0.000 claims description 12
- 238000005859 coupling reaction Methods 0.000 claims description 12
- 208000019622 heart disease Diseases 0.000 claims description 12
- 208000006218 bradycardia Diseases 0.000 claims description 11
- 230000036471 bradycardia Effects 0.000 claims description 11
- 230000008878 coupling Effects 0.000 claims description 11
- 210000005242 cardiac chamber Anatomy 0.000 claims description 10
- 230000008859 change Effects 0.000 claims description 9
- 206010003130 Arrhythmia supraventricular Diseases 0.000 claims description 7
- 206010065341 Ventricular tachyarrhythmia Diseases 0.000 claims description 6
- 238000001914 filtration Methods 0.000 claims description 5
- 208000023504 respiratory system disease Diseases 0.000 claims description 5
- 229940030602 cardiac therapy drug Drugs 0.000 claims description 4
- 230000005856 abnormality Effects 0.000 claims description 3
- 230000005540 biological transmission Effects 0.000 claims description 3
- 230000004936 stimulating effect Effects 0.000 claims description 3
- 230000007704 transition Effects 0.000 claims description 3
- 206010016207 Familial Mediterranean fever Diseases 0.000 claims description 2
- 208000003663 ventricular fibrillation Diseases 0.000 description 23
- 238000013459 approach Methods 0.000 description 22
- 238000010586 diagram Methods 0.000 description 20
- 230000008569 process Effects 0.000 description 19
- 210000002620 vena cava superior Anatomy 0.000 description 19
- 210000005241 right ventricle Anatomy 0.000 description 17
- 230000008602 contraction Effects 0.000 description 16
- 238000007726 management method Methods 0.000 description 15
- 210000001519 tissue Anatomy 0.000 description 15
- 238000002513 implantation Methods 0.000 description 14
- 210000005240 left ventricle Anatomy 0.000 description 13
- 238000012545 processing Methods 0.000 description 13
- 210000002837 heart atrium Anatomy 0.000 description 12
- 210000005245 right atrium Anatomy 0.000 description 12
- 206010019280 Heart failures Diseases 0.000 description 10
- 239000012190 activator Substances 0.000 description 9
- 238000012806 monitoring device Methods 0.000 description 8
- 238000002633 shock therapy Methods 0.000 description 8
- 210000002027 skeletal muscle Anatomy 0.000 description 8
- 230000006794 tachycardia Effects 0.000 description 8
- 238000007792 addition Methods 0.000 description 7
- 230000004217 heart function Effects 0.000 description 7
- 238000013461 design Methods 0.000 description 6
- 238000011156 evaluation Methods 0.000 description 6
- 210000005246 left atrium Anatomy 0.000 description 6
- 230000009467 reduction Effects 0.000 description 6
- 230000001225 therapeutic effect Effects 0.000 description 6
- 239000013598 vector Substances 0.000 description 6
- 206010007559 Cardiac failure congestive Diseases 0.000 description 5
- 230000002159 abnormal effect Effects 0.000 description 5
- 210000000038 chest Anatomy 0.000 description 5
- 210000003748 coronary sinus Anatomy 0.000 description 5
- 230000004069 differentiation Effects 0.000 description 5
- 210000005003 heart tissue Anatomy 0.000 description 5
- 230000001360 synchronised effect Effects 0.000 description 5
- 210000003462 vein Anatomy 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 238000002847 impedance measurement Methods 0.000 description 4
- 230000002107 myocardial effect Effects 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- 206010003658 Atrial Fibrillation Diseases 0.000 description 3
- 206010047281 Ventricular arrhythmia Diseases 0.000 description 3
- 230000004913 activation Effects 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 206010061592 cardiac fibrillation Diseases 0.000 description 3
- 238000009125 cardiac resynchronization therapy Methods 0.000 description 3
- 238000012790 confirmation Methods 0.000 description 3
- 238000013480 data collection Methods 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000002224 dissection Methods 0.000 description 3
- 238000012377 drug delivery Methods 0.000 description 3
- 230000004064 dysfunction Effects 0.000 description 3
- 230000002600 fibrillogenic effect Effects 0.000 description 3
- 230000001788 irregular Effects 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 210000004165 myocardium Anatomy 0.000 description 3
- 230000007935 neutral effect Effects 0.000 description 3
- 230000029058 respiratory gaseous exchange Effects 0.000 description 3
- 230000007958 sleep Effects 0.000 description 3
- 210000005166 vasculature Anatomy 0.000 description 3
- 206010049418 Sudden Cardiac Death Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 239000003416 antiarrhythmic agent Substances 0.000 description 2
- 238000003491 array Methods 0.000 description 2
- 230000000712 assembly Effects 0.000 description 2
- 238000000429 assembly Methods 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 239000002371 cardiac agent Substances 0.000 description 2
- 210000004903 cardiac system Anatomy 0.000 description 2
- 210000003109 clavicle Anatomy 0.000 description 2
- 239000004020 conductor Substances 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000001934 delay Effects 0.000 description 2
- 230000003111 delayed effect Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000000977 initiatory effect Effects 0.000 description 2
- 230000003601 intercostal effect Effects 0.000 description 2
- 230000007787 long-term memory Effects 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000000877 morphologic effect Effects 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 238000005086 pumping Methods 0.000 description 2
- LOUPRKONTZGTKE-LHHVKLHASA-N quinidine Chemical compound C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@H]2[C@@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-LHHVKLHASA-N 0.000 description 2
- 230000000241 respiratory effect Effects 0.000 description 2
- 230000001020 rhythmical effect Effects 0.000 description 2
- 238000007493 shaping process Methods 0.000 description 2
- 210000001321 subclavian vein Anatomy 0.000 description 2
- 206010003662 Atrial flutter Diseases 0.000 description 1
- 208000020446 Cardiac disease Diseases 0.000 description 1
- 206010056370 Congestive cardiomyopathy Diseases 0.000 description 1
- 201000010046 Dilated cardiomyopathy Diseases 0.000 description 1
- DJBNUMBKLMJRSA-UHFFFAOYSA-N Flecainide Chemical compound FC(F)(F)COC1=CC=C(OCC(F)(F)F)C(C(=O)NCC2NCCCC2)=C1 DJBNUMBKLMJRSA-UHFFFAOYSA-N 0.000 description 1
- 206010021079 Hypopnoea Diseases 0.000 description 1
- ALOBUEHUHMBRLE-UHFFFAOYSA-N Ibutilide Chemical compound CCCCCCCN(CC)CCCC(O)C1=CC=C(NS(C)(=O)=O)C=C1 ALOBUEHUHMBRLE-UHFFFAOYSA-N 0.000 description 1
- 206010049694 Left Ventricular Dysfunction Diseases 0.000 description 1
- 244000261422 Lysimachia clethroides Species 0.000 description 1
- 208000004301 Sinus Arrhythmia Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 229960005260 amiodarone Drugs 0.000 description 1
- IYIKLHRQXLHMJQ-UHFFFAOYSA-N amiodarone Chemical compound CCCCC=1OC2=CC=CC=C2C=1C(=O)C1=CC(I)=C(OCCN(CC)CC)C(I)=C1 IYIKLHRQXLHMJQ-UHFFFAOYSA-N 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000007175 bidirectional communication Effects 0.000 description 1
- 230000002146 bilateral effect Effects 0.000 description 1
- 239000000560 biocompatible material Substances 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 208000030303 breathing problems Diseases 0.000 description 1
- 210000004289 cerebral ventricle Anatomy 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- LOUPRKONTZGTKE-UHFFFAOYSA-N cinchonine Natural products C1C(C(C2)C=C)CCN2C1C(O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-UHFFFAOYSA-N 0.000 description 1
- 238000002648 combination therapy Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000011157 data evaluation Methods 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 229960001066 disopyramide Drugs 0.000 description 1
- UVTNFZQICZKOEM-UHFFFAOYSA-N disopyramide Chemical compound C=1C=CC=NC=1C(C(N)=O)(CCN(C(C)C)C(C)C)C1=CC=CC=C1 UVTNFZQICZKOEM-UHFFFAOYSA-N 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 229940066220 doctor's choice Drugs 0.000 description 1
- 229960002994 dofetilide Drugs 0.000 description 1
- IXTMWRCNAAVVAI-UHFFFAOYSA-N dofetilide Chemical compound C=1C=C(NS(C)(=O)=O)C=CC=1CCN(C)CCOC1=CC=C(NS(C)(=O)=O)C=C1 IXTMWRCNAAVVAI-UHFFFAOYSA-N 0.000 description 1
- 238000010292 electrical insulation Methods 0.000 description 1
- 230000000763 evoking effect Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 229960000449 flecainide Drugs 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000000446 fuel Substances 0.000 description 1
- 230000010247 heart contraction Effects 0.000 description 1
- 229960004053 ibutilide Drugs 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 239000003589 local anesthetic agent Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000007769 metal material Substances 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 230000007830 nerve conduction Effects 0.000 description 1
- 230000007383 nerve stimulation Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 238000010837 poor prognosis Methods 0.000 description 1
- 229960000244 procainamide Drugs 0.000 description 1
- REQCZEXYDRLIBE-UHFFFAOYSA-N procainamide Chemical compound CCN(CC)CCNC(=O)C1=CC=C(N)C=C1 REQCZEXYDRLIBE-UHFFFAOYSA-N 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 229960001404 quinidine Drugs 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000034225 regulation of ventricular cardiomyocyte membrane depolarization Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 201000002859 sleep apnea Diseases 0.000 description 1
- 230000003860 sleep quality Effects 0.000 description 1
- ZBMZVLHSJCTVON-UHFFFAOYSA-N sotalol Chemical compound CC(C)NCC(O)C1=CC=C(NS(C)(=O)=O)C=C1 ZBMZVLHSJCTVON-UHFFFAOYSA-N 0.000 description 1
- 229960002370 sotalol Drugs 0.000 description 1
- 238000011301 standard therapy Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000000153 supplemental effect Effects 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000026676 system process Effects 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 210000000596 ventricular septum Anatomy 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/362—Heart stimulators
- A61N1/365—Heart stimulators controlled by a physiological parameter, e.g. heart potential
- A61N1/368—Heart stimulators controlled by a physiological parameter, e.g. heart potential comprising more than one electrode co-operating with different heart regions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/362—Heart stimulators
- A61N1/37—Monitoring; Protecting
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/372—Arrangements in connection with the implantation of stimulators
- A61N1/375—Constructional arrangements, e.g. casings
- A61N1/3752—Details of casing-lead connections
Landscapes
- Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biophysics (AREA)
- Physiology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Electrotherapy Devices (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US46227203P | 2003-04-11 | 2003-04-11 | |
| US10/462,001 US20040230229A1 (en) | 2003-04-11 | 2003-06-13 | Hybrid transthoracic/intrathoracic cardiac stimulation devices and methods |
| US10/785,431 US20050004615A1 (en) | 2003-04-11 | 2004-02-24 | Reconfigurable implantable cardiac monitoring and therapy delivery device |
| US10/821,248 US20040215240A1 (en) | 2003-04-11 | 2004-04-08 | Reconfigurable subcutaneous cardiac device |
| PCT/US2004/010908 WO2004091720A2 (en) | 2003-04-11 | 2004-04-09 | Subcutaneous cardiac device |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006522659A true JP2006522659A (ja) | 2006-10-05 |
| JP2006522659A5 JP2006522659A5 (enExample) | 2007-06-28 |
Family
ID=33304106
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006509832A Pending JP2006522659A (ja) | 2003-04-11 | 2004-04-09 | 皮下用心臓デバイス |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP1613395A2 (enExample) |
| JP (1) | JP2006522659A (enExample) |
| WO (1) | WO2004091720A2 (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2013524997A (ja) * | 2010-04-29 | 2013-06-20 | カーディアック ペースメイカーズ, インコーポレイテッド | ポート使用状況に基づく植込み型医療機器の構成 |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7392085B2 (en) | 2001-11-21 | 2008-06-24 | Cameron Health, Inc. | Multiple electrode vectors for implantable cardiac treatment devices |
| US7330757B2 (en) | 2001-11-21 | 2008-02-12 | Cameron Health, Inc. | Method for discriminating between ventricular and supraventricular arrhythmias |
| US20060247693A1 (en) | 2005-04-28 | 2006-11-02 | Yanting Dong | Non-captured intrinsic discrimination in cardiac pacing response classification |
| US7774064B2 (en) | 2003-12-12 | 2010-08-10 | Cardiac Pacemakers, Inc. | Cardiac response classification using retriggerable classification windows |
| US7647108B2 (en) | 2004-09-30 | 2010-01-12 | Cardiac Pacemakers, Inc. | Methods and systems for selection of cardiac pacing electrode configurations |
| US8214035B2 (en) | 2004-12-17 | 2012-07-03 | Medtronic, Inc. | System and method for utilizing brain state information to modulate cardiac therapy |
| US8485979B2 (en) | 2004-12-17 | 2013-07-16 | Medtronic, Inc. | System and method for monitoring or treating nervous system disorders |
| US8112148B2 (en) | 2004-12-17 | 2012-02-07 | Medtronic, Inc. | System and method for monitoring cardiac signal activity in patients with nervous system disorders |
| US8108046B2 (en) | 2004-12-17 | 2012-01-31 | Medtronic, Inc. | System and method for using cardiac events to trigger therapy for treating nervous system disorders |
| US8209019B2 (en) | 2004-12-17 | 2012-06-26 | Medtronic, Inc. | System and method for utilizing brain state information to modulate cardiac therapy |
| US8112153B2 (en) | 2004-12-17 | 2012-02-07 | Medtronic, Inc. | System and method for monitoring or treating nervous system disorders |
| DE602005026054D1 (de) | 2004-12-17 | 2011-03-03 | Medtronic Inc | System zur überwachung oder behandlung von erkrankungen des nervensystems |
| US8209009B2 (en) | 2004-12-17 | 2012-06-26 | Medtronic, Inc. | System and method for segmenting a cardiac signal based on brain stimulation |
| US8160697B2 (en) | 2005-01-25 | 2012-04-17 | Cameron Health, Inc. | Method for adapting charge initiation for an implantable cardioverter-defibrillator |
| US8229563B2 (en) | 2005-01-25 | 2012-07-24 | Cameron Health, Inc. | Devices for adapting charge initiation for an implantable cardioverter-defibrillator |
| US8116867B2 (en) | 2005-08-04 | 2012-02-14 | Cameron Health, Inc. | Methods and devices for tachyarrhythmia sensing and high-pass filter bypass |
| WO2007035687A2 (en) | 2005-09-16 | 2007-03-29 | The Ohio State University | Method and apparatus for detecting interventricular dyssynchrony |
| US8280136B2 (en) | 2005-09-16 | 2012-10-02 | The Ohio State University | Method and apparatus for detecting intraventricular dyssynchrony |
| US8200341B2 (en) | 2007-02-07 | 2012-06-12 | Cameron Health, Inc. | Sensing vector selection in a cardiac stimulus device with postural assessment |
| US8788023B2 (en) | 2006-05-26 | 2014-07-22 | Cameron Health, Inc. | Systems and methods for sensing vector selection in an implantable medical device |
| US7783340B2 (en) | 2007-01-16 | 2010-08-24 | Cameron Health, Inc. | Systems and methods for sensing vector selection in an implantable medical device using a polynomial approach |
| US7623909B2 (en) | 2006-05-26 | 2009-11-24 | Cameron Health, Inc. | Implantable medical devices and programmers adapted for sensing vector selection |
| US8948867B2 (en) | 2006-09-14 | 2015-02-03 | Cardiac Pacemakers, Inc. | Capture detection with cross chamber backup pacing |
| US8000788B2 (en) | 2007-04-27 | 2011-08-16 | Medtronic, Inc. | Implantable medical device for treating neurological conditions including ECG sensing |
| WO2008133683A1 (en) * | 2007-04-27 | 2008-11-06 | Medtronic, Inc. | Implantable medical device for treating neurological conditions with an initially disabled cardiac therepy port and leadless ecg sensing |
| US8265736B2 (en) | 2007-08-07 | 2012-09-11 | Cardiac Pacemakers, Inc. | Method and apparatus to perform electrode combination selection |
| US9037239B2 (en) | 2007-08-07 | 2015-05-19 | Cardiac Pacemakers, Inc. | Method and apparatus to perform electrode combination selection |
| JP5276119B2 (ja) | 2008-02-14 | 2013-08-28 | カーディアック ペースメイカーズ, インコーポレイテッド | 横隔刺激検出のための方法および装置 |
| WO2014164530A1 (en) | 2013-03-11 | 2014-10-09 | Cameron Health, Inc. | Methods and devices implementing dual criteria for arrhythmia detection |
| US9579065B2 (en) | 2013-03-12 | 2017-02-28 | Cameron Health Inc. | Cardiac signal vector selection with monophasic and biphasic shape consideration |
| US11324954B2 (en) | 2019-06-28 | 2022-05-10 | Covidien Lp | Achieving smooth breathing by modified bilateral phrenic nerve pacing |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5318594A (en) * | 1990-11-30 | 1994-06-07 | Ela Medical | DDD type cardiac pacemaker having automatic operating mode switching |
| US5313953A (en) | 1992-01-14 | 1994-05-24 | Incontrol, Inc. | Implantable cardiac patient monitor |
| US5601607A (en) * | 1992-03-19 | 1997-02-11 | Angeion Corporation | Implantable cardioverter defibrillator housing plated electrode |
| US5411031A (en) | 1993-11-24 | 1995-05-02 | Incontrol, Inc. | Implantable cardiac patient monitor |
| US5620466A (en) | 1995-08-14 | 1997-04-15 | Cardiac Pacemakers, Inc. | Digital AGC using separate gain control and threshold templating |
| US5662688A (en) | 1995-08-14 | 1997-09-02 | Cardiac Pacemakers, Inc. | Slow gain control |
| US6556862B2 (en) * | 1998-03-19 | 2003-04-29 | Cardiac Pacemakers, Inc. | Method and apparatus for treating supraventricular tachyarrhythmias |
| US6144880A (en) | 1998-05-08 | 2000-11-07 | Cardiac Pacemakers, Inc. | Cardiac pacing using adjustable atrio-ventricular delays |
| US6055454A (en) | 1998-07-27 | 2000-04-25 | Cardiac Pacemakers, Inc. | Cardiac pacemaker with automatic response optimization of a physiologic sensor based on a second sensor |
| WO2000009206A1 (en) * | 1998-08-17 | 2000-02-24 | Medtronic, Inc. | Method and apparatus for prevention of atrial tachyarrhythmias |
| US6044298A (en) | 1998-10-13 | 2000-03-28 | Cardiac Pacemakers, Inc. | Optimization of pacing parameters based on measurement of integrated acoustic noise |
| FR2801798B1 (fr) * | 1999-12-02 | 2002-05-17 | Ela Medical Sa | Dispositif medical implantable actif, notamment stimulateur cardiaque, defibrillateur et/ou cardiovecteur de type multisite, comportant des moyens de detection des tachycardies induites |
| US7194309B2 (en) * | 2000-09-18 | 2007-03-20 | Cameron Health, Inc. | Packaging technology for non-transvenous cardioverter/defibrillator devices |
| US6609027B2 (en) * | 2001-02-23 | 2003-08-19 | Pacesetter, Inc. | His Bundle sensing device and associated method |
| US6895273B2 (en) * | 2001-04-06 | 2005-05-17 | Cardiac Pacemakers, Inc. | Temporary tachyarrhythmia therapy modes for electrophysiologic testing |
| US6708058B2 (en) * | 2001-04-30 | 2004-03-16 | Cardiac Pacemakers, Inc. | Normal cardiac rhythm template generation system and method |
| US6731982B1 (en) * | 2001-10-19 | 2004-05-04 | Pacesetter, Inc. | Anti-tachycardia pacing methods and devices |
-
2004
- 2004-04-09 WO PCT/US2004/010908 patent/WO2004091720A2/en not_active Ceased
- 2004-04-09 EP EP04759310A patent/EP1613395A2/en not_active Withdrawn
- 2004-04-09 JP JP2006509832A patent/JP2006522659A/ja active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2013524997A (ja) * | 2010-04-29 | 2013-06-20 | カーディアック ペースメイカーズ, インコーポレイテッド | ポート使用状況に基づく植込み型医療機器の構成 |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004091720A3 (en) | 2005-02-03 |
| WO2004091720A2 (en) | 2004-10-28 |
| EP1613395A2 (en) | 2006-01-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006522659A (ja) | 皮下用心臓デバイス | |
| US20040215240A1 (en) | Reconfigurable subcutaneous cardiac device | |
| US7570997B2 (en) | Subcutaneous cardiac rhythm management with asystole prevention therapy | |
| US20040230229A1 (en) | Hybrid transthoracic/intrathoracic cardiac stimulation devices and methods | |
| JP5059618B2 (ja) | 心臓刺激システム | |
| JP5364167B2 (ja) | 内因性伝導に基づく心臓再同期療法モード選択のための方法および装置 | |
| US11590353B2 (en) | Intra-body device communication with redundant message transmission | |
| US8116868B2 (en) | Implantable device with cardiac event audio playback | |
| US20130268016A1 (en) | Systems and methods for controlling spinal cord stimulation to improve stimulation efficacy for use by implantable medical devices | |
| EP3024539B1 (en) | Combination of feedback on mechanical and electrical resynchronization to select therapy parameters | |
| US8000786B2 (en) | Multiple pulse defibrillation for subcutaneous implantable cardiac devices | |
| US10463866B2 (en) | Systems and methods for treating cardiac arrhythmias | |
| JP2006522650A (ja) | 心臓に対する皮下電極位置決め方法およびシステム | |
| JP2010509986A (ja) | 心臓賦活シーケンス情報を利用する心臓再同期治療の最適化 | |
| WO2012057857A1 (en) | Supraventricular stimulation to control ventricular rate | |
| US20040220628A1 (en) | Subcutaneous defibrillation timing correlated with induced skeletal muscle contraction | |
| US20130053918A1 (en) | Left-ventricular pacing site selection guided by electrogram morphology analysis | |
| US8634911B2 (en) | Pacing interval determination for ventricular dyssynchrony | |
| EP2459278B1 (en) | Terminating tachyarrhythmias |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070406 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20070406 |
|
| RD03 | Notification of appointment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7423 Effective date: 20090206 |
|
| RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20090212 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20090630 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20091124 |